Tumour motion analysis from planning to end of treatment course for a large cohort of peripheral lung SBRT targets

Tine Bjørn Nielsen, Carsten Brink, Stefan Starup Jeppesen, Tine Schytte, Olfred Hansen, Morten Nielsen*

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Background: The aim is to quantify and analyse tumour motion during a course of treatment for lung SBRT patients. Material and methods: Peak-to-peak motion of 483 tumours in 441 patients treated with peripheral lung SBRT at a single institution over a two year period was measured on planning CT and at all treatment fractions. Planning 4D-CT scans were analysed using our clinical workflow involving deformable propagation of the delineated target to all phases. Similarly, acquisition of the 4D-CBCT data followed the clinical workflow based on XVI 5.0 available on Elekta linacs. Differences and correlations of the peak-to-peak motion on the planning CT and at treatment were analysed. Results: On the planning CT, a total of 81.4% of the tumours had a peak-to-peak motion <10 mm, and 96.1% had <20 mm. The largest motion was observed in the CC direction, with largest amplitude for tumours located in the caudal posterior part of the lung. The difference in amplitude in CC between planning CT and first fraction had a mean and standard deviation of 0.3 mm and 3.5 mm, respectively, and the largest differences were observed in the caudal posterior part of the lung. Patients with a difference in tumour motion amplitude exceeding two standard deviations (>7 mm) at the first fraction were evaluated individually, and they all had poor 4DCT image quality. The difference between the first and second/third fractions had a mean and standard deviation of 0.4 mm/0.5 mm and 2.0 mm/1.9 mm. Conclusion: Tumour motion at first treatment was similar to motion at planning, and motion at subsequent treatments was very similar to motion at first treatment. Large tumour motions are located towards the caudal posterior tumour locations. Patients with poor 4D-CT image quality should be closely followed at the first treatment to verify the motion.

OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind60
Udgave nummer11
Sider (fra-til)1407-1412
ISSN0284-186X
DOI
StatusUdgivet - nov. 2021

Bibliografisk note

Publisher Copyright:
© 2021 Acta Oncologica Foundation.

Fingeraftryk

Dyk ned i forskningsemnerne om 'Tumour motion analysis from planning to end of treatment course for a large cohort of peripheral lung SBRT targets'. Sammen danner de et unikt fingeraftryk.

Citationsformater